Cargando…

Treatment of estrogen-induced dermatitis with omalizumab

Detalles Bibliográficos
Autores principales: Ocana, Jesus A., Bell, Maria C., Heskett, Jordan B., Baker, William H., Mousdicas, Nico, Turner, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536736/
https://www.ncbi.nlm.nih.gov/pubmed/31193571
http://dx.doi.org/10.1016/j.jdcr.2019.03.007
_version_ 1783421831626096640
author Ocana, Jesus A.
Bell, Maria C.
Heskett, Jordan B.
Baker, William H.
Mousdicas, Nico
Turner, Matthew J.
author_facet Ocana, Jesus A.
Bell, Maria C.
Heskett, Jordan B.
Baker, William H.
Mousdicas, Nico
Turner, Matthew J.
author_sort Ocana, Jesus A.
collection PubMed
description
format Online
Article
Text
id pubmed-6536736
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-65367362019-06-03 Treatment of estrogen-induced dermatitis with omalizumab Ocana, Jesus A. Bell, Maria C. Heskett, Jordan B. Baker, William H. Mousdicas, Nico Turner, Matthew J. JAAD Case Rep Case Report Elsevier 2019-05-25 /pmc/articles/PMC6536736/ /pubmed/31193571 http://dx.doi.org/10.1016/j.jdcr.2019.03.007 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ocana, Jesus A.
Bell, Maria C.
Heskett, Jordan B.
Baker, William H.
Mousdicas, Nico
Turner, Matthew J.
Treatment of estrogen-induced dermatitis with omalizumab
title Treatment of estrogen-induced dermatitis with omalizumab
title_full Treatment of estrogen-induced dermatitis with omalizumab
title_fullStr Treatment of estrogen-induced dermatitis with omalizumab
title_full_unstemmed Treatment of estrogen-induced dermatitis with omalizumab
title_short Treatment of estrogen-induced dermatitis with omalizumab
title_sort treatment of estrogen-induced dermatitis with omalizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536736/
https://www.ncbi.nlm.nih.gov/pubmed/31193571
http://dx.doi.org/10.1016/j.jdcr.2019.03.007
work_keys_str_mv AT ocanajesusa treatmentofestrogeninduceddermatitiswithomalizumab
AT bellmariac treatmentofestrogeninduceddermatitiswithomalizumab
AT heskettjordanb treatmentofestrogeninduceddermatitiswithomalizumab
AT bakerwilliamh treatmentofestrogeninduceddermatitiswithomalizumab
AT mousdicasnico treatmentofestrogeninduceddermatitiswithomalizumab
AT turnermatthewj treatmentofestrogeninduceddermatitiswithomalizumab